These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30141622)

  • 21. Photoswitchable Serotonins for Optical Control of the 5-HT
    Morstein J; Romano G; Hetzler BE; Plante A; Haake C; Levitz J; Trauner D
    Angew Chem Int Ed Engl; 2022 Apr; 61(18):e202117094. PubMed ID: 34989082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanobodies to Study G Protein-Coupled Receptor Structure and Function.
    Manglik A; Kobilka BK; Steyaert J
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():19-37. PubMed ID: 27959623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly biased agonism for GPCR ligands via nanobody tethering.
    Sachdev S; Creemer BA; Gardella TJ; Cheloha RW
    Nat Commun; 2024 Jun; 15(1):4687. PubMed ID: 38824166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A nanobody activating metabotropic glutamate receptor 4 discriminates between homo- and heterodimers.
    Haubrich J; Font J; Quast RB; Goupil-Lamy A; Scholler P; Nevoltris D; Acher F; Chames P; Rondard P; Prézeau L; Pin JP
    Proc Natl Acad Sci U S A; 2021 Aug; 118(33):. PubMed ID: 34385321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
    De Groof TWM; Bobkov V; Heukers R; Smit MJ
    Mol Cell Endocrinol; 2019 Mar; 484():15-24. PubMed ID: 30690070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of surface plasmon resonance imaging to monitoring G protein-coupled receptor signaling and its modulation in a heterologous expression system.
    Nonobe Y; Yokoyama T; Kamikubo Y; Yoshida S; Hisajima N; Shinohara H; Shiraishi Y; Sakurai T; Tabata T
    BMC Biotechnol; 2016 Apr; 16():36. PubMed ID: 27068216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanobodies and their Use in GPCR Drug Discovery.
    Cromie KD; Van Heeke G; Boutton C
    Curr Top Med Chem; 2015; 15(24):2543-57. PubMed ID: 26126902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditional control of fluorescent protein degradation by an auxin-dependent nanobody.
    Daniel K; Icha J; Horenburg C; Müller D; Norden C; Mansfeld J
    Nat Commun; 2018 Aug; 9(1):3297. PubMed ID: 30120238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graded activation and free energy landscapes of a muscarinic G-protein-coupled receptor.
    Miao Y; McCammon JA
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12162-12167. PubMed ID: 27791003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic mass redistribution reveals diverging importance of PDZ-ligands for G protein-coupled receptor pharmacodynamics.
    Camp ND; Lee KS; Cherry A; Wacker-Mhyre JL; Kountz TS; Park JM; Harris DA; Estrada M; Stewart A; Stella N; Wolf-Yadlin A; Hague C
    Pharmacol Res; 2016 Mar; 105():13-21. PubMed ID: 26773201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical biology methods for investigating G protein-coupled receptor signaling.
    Huber T; Sakmar TP
    Chem Biol; 2014 Sep; 21(9):1224-37. PubMed ID: 25237865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically encoded photocrosslinkers as molecular probes to study G-protein-coupled receptors (GPCRs).
    Beck-Sickinger AG; Budisa N
    Angew Chem Int Ed Engl; 2012 Jan; 51(2):310-2. PubMed ID: 22128109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology.
    Hauwert NJ; Mocking TAM; Da Costa Pereira D; Kooistra AJ; Wijnen LM; Vreeker GCM; Verweij EWE; De Boer AH; Smit MJ; De Graaf C; Vischer HF; de Esch IJP; Wijtmans M; Leurs R
    J Am Chem Soc; 2018 Mar; 140(12):4232-4243. PubMed ID: 29470065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A fluorescent ligand-binding alternative using Tag-lite® technology.
    Zwier JM; Roux T; Cottet M; Durroux T; Douzon S; Bdioui S; Gregor N; Bourrier E; Oueslati N; Nicolas L; Tinel N; Boisseau C; Yverneau P; Charrier-Savournin F; Fink M; Trinquet E
    J Biomol Screen; 2010 Dec; 15(10):1248-59. PubMed ID: 20974902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of metabotropic receptors of serotonin, dopamine, GABA, glutamate, and short neuropeptide F in the central complex of Drosophila.
    Kahsai L; Carlsson MA; Winther AM; Nässel DR
    Neuroscience; 2012 Apr; 208():11-26. PubMed ID: 22361394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescent ligands, antibodies, and proteins for the study of receptors.
    Daly CJ; McGrath JC
    Pharmacol Ther; 2003 Nov; 100(2):101-18. PubMed ID: 14609715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in tethered photopharmacology for precise optical control of signaling proteins.
    Broichhagen J; Levitz J
    Curr Opin Pharmacol; 2022 Apr; 63():102196. PubMed ID: 35245800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion proteins as model systems for the analysis of constitutive GPCR activity.
    Schneider EH; Seifert R
    Methods Enzymol; 2010; 485():459-80. PubMed ID: 21050932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of GRK2 RH domain-dependent regulation of GPCR coupling to heterotrimeric G proteins.
    Sterne-Marr R; Dhami GK; Tesmer JJ; Ferguson SS
    Methods Enzymol; 2004; 390():310-36. PubMed ID: 15488186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.